PATENT CLAIM ANALYSIS

Application Number: 16057335
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-03
Patent Classification: ["514", "220000"]

Abstract:
Provided are methods of administering glycerol phenylbutyrate to a patient in need thereof, wherein said patient is also being treated with a CYP3A4 substrate having a narrow therapeutic index, midazolam or a pharmaceutically acceptable salt thereof, or celecoxib.

Claim (Index 30):
The method of  claim 28 , wherein the patient is an infant or pediatric and the method further comprises adjusting the glycerol phenylbutyrate dosage to keep the first ammonia of the morning below the upper limit of normal.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 96.0
- Lexical Diversity: 1.23529
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12350111', '12784738', '12272873', '13271830', '13224589']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7521904117480218
- 35 USC 102 Novelty (BERT): 0.5119788419354974
- Combined Prediction Score: 0.7281692547667694
- Mean Citation Score: 210.76274
- Max Citation Score: 221.66754
- Similarity Product: 134.25718849853754

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test